Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: Effects on virus replication and recurrent hepatitis

doi:10.3748/wjg.v12.i5.697

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2838)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

311

HTML

2122

Figures (1-5)

215

Tables (1-2)

190

Sum=2838

Feb 7, 2006 (publication date) through Dec 2, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Feb 7, 2006; 12(5): 697-702
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.697

Full Size Figure Download Figure

Figure 4 Proportion of HCV-infected patients under CsA or Tac medication with normal transaminase activities at different time points post LTx. A: Percentage of patients with normal ALT; B: percentage of patients with normal and AST. P-values were calculated by x² test.

Citation: Hilgard P, Kahraman A, Lehmann N, Seltmann C, Beckebaum S, Ross RS, Baba HA, Malago M, Broelsch CE, Gerken G. Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: Effects on virus replication and recurrent hepatitis. World J Gastroenterol 2006; 12(5): 697-702
URL: https://www.wjgnet.com/1007-9327/full/v12/i5/697.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i5.697